FDA in­spec­tion at Catal­ent’s Bel­gium fa­cil­i­ty un­cov­ers da­ta, equip­ment and oth­er QC is­sues

On­ly a month af­ter FDA in­spect­ed Catal­ent’s site in In­di­ana, a site in Eu­rope has sim­i­lar­ly re­ceived an in­spec­tion re­port from US reg­u­la­tors, this time …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER